Roum Arch Microbiol Immunol. 2006 Jan-Jun;65(1-2):66-74.

Costimulatory molecule CD154 in systemic lupus erythematosus and rheumatoid arthritis. Therapeutic perspectives.

Source

Department of Immunopathology, University of Medicine and Pharmacy "Iuliu Hatieganu", Cluj-Napoca, Romania.

Abstract

SLE is a systemic autoimmune disease characterized by B cell hyperactivity. Evidence from the last years has shown that B cells play a key role in the development of the immune response. The interaction of CD40 on B cells with its ligand CD154 on activated T cells provides a costimulatory signal that induces T dependent B cell proliferation and differentiation with subsequent antibody production. Moreover, CD154 can act as a cytokine, in addition to its main role to mediate the interactions between T and CD40+ target cells. This review focuses on the multiple roles of CD154 in systemic lupus erythematosus and rheumatoid arthritis and its involvement in the humoral immunity disregulation of patients with these diseases. It also takes in consideration the most recent therapeutic perspectives regarding the use of monoclonal antibodies against CD154, which might be a powerful tool in the treatment of these diseases in the future.

PMID:: 17877113; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

Review

MeSH Terms

Substances

LinkOut - more resources

Medical

Supplemental Content

Save items

Related citations in PubMed

Peripheral blood lymphocytes in SLE--hyperexpression of CD154 on T and B lymphocytes and increased number of double negative T cells. [J Autoimmun. 1998]
Peripheral blood lymphocytes in SLE--hyperexpression of CD154 on T and B lymphocytes and increased number of double negative T cells.
Devi BS, Van Noordin S, Krausz T, Davies KA. J Autoimmun. 1998 Oct; 11(5):471-5.
Review T cells in the pathogenesis of systemic lupus erythematosus: potential roles of CD154-CD40 interactions and costimulatory molecules. [Curr Rheumatol Rep. 2000]
Review T cells in the pathogenesis of systemic lupus erythematosus: potential roles of CD154-CD40 interactions and costimulatory molecules.
Yellin MJ, Thienel U. Curr Rheumatol Rep. 2000 Feb; 2(1):24-31.
Review CD154: an immunoinflammatory mediator in systemic lupus erythematosus and rheumatoid arthritis. [Clin Dev Immunol. 2012]
Review CD154: an immunoinflammatory mediator in systemic lupus erythematosus and rheumatoid arthritis.
Alaaeddine N, Hassan GS, Yacoub D, Mourad W. Clin Dev Immunol. 2012; 2012:490148. Epub 2011 Oct 24.
Abnormal germinal center reactions in systemic lupus erythematosus demonstrated by blockade of CD154-CD40 interactions. [J Clin Invest. 2003]
Abnormal germinal center reactions in systemic lupus erythematosus demonstrated by blockade of CD154-CD40 interactions.
Grammer AC, Slota R, Fischer R, Gur H, Girschick H, Yarboro C, Illei GG, Lipsky PE. J Clin Invest. 2003 Nov; 112(10):1506-20.
Preferential expression of B7.2 (CD86), but not B7.1 (CD80), on B cells induced by CD40/CD40L interaction is essential for anti-DNA autoantibody production in patients with systemic lupus erythematosus. [Clin Exp Rheumatol. 2003]
Preferential expression of B7.2 (CD86), but not B7.1 (CD80), on B cells induced by CD40/CD40L interaction is essential for anti-DNA autoantibody production in patients with systemic lupus erythematosus.
Nagafuchi H, Shimoyama Y, Kashiwakura J, Takeno M, Sakane T, Suzuki N. Clin Exp Rheumatol. 2003 Jan-Feb; 21(1):71-7.

See reviews... See all...

Cited by 1 PubMed Central article

Orbital fibroblasts from patients with thyroid-associated ophthalmopathy overexpress CD40: CD154 hyperinduces IL-6, IL-8, and MCP-1. [Invest Ophthalmol Vis Sci. 2009]
Orbital fibroblasts from patients with thyroid-associated ophthalmopathy overexpress CD40: CD154 hyperinduces IL-6, IL-8, and MCP-1.
Hwang CJ, Afifiyan N, Sand D, Naik V, Said J, Pollock SJ, Chen B, Phipps RP, Goldberg RA, Smith TJ, et al. Invest Ophthalmol Vis Sci. 2009 May; 50(5):2262-8. Epub 2008 Dec 30.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Costimulatory molecule CD154 in systemic lupus erythematosus and rheumatoid arth...
Costimulatory molecule CD154 in systemic lupus erythematosus and rheumatoid arthritis. Therapeutic perspectives.
Roum Arch Microbiol Immunol. 2006 Jan-Jun ;65(1-2):66-74.

PubMed
2007 Elizabeth Winston Lanier Award Winner. Magnetic resonance imaging of cartil...
2007 Elizabeth Winston Lanier Award Winner. Magnetic resonance imaging of cartilage glycosaminoglycan: basic principles, imaging technique, and clinical applications.
J Orthop Res. 2008 Mar ;26(3):281-91.

PubMed
Is it genomic imprinting or preferential expression?
Is it genomic imprinting or preferential expression?
Bioessays. 2007 Oct ;29(10):1022-8.

PubMed
The characterization of a murine model of mucopolysaccharidosis II (Hunter syndr...
The characterization of a murine model of mucopolysaccharidosis II (Hunter syndrome).
J Inherit Metab Dis. 2007 Nov ;30(6):924-34. Epub 2007 Sep 16 .

PubMed
Surgery for rectal cancer performed at teaching hospitals improves survival and ...
Surgery for rectal cancer performed at teaching hospitals improves survival and preserves continence.
J Gastrointest Surg. 2007 Nov ;11(11):1441-8; discussion 1448-50. Epub 2007 Sep 18 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: